Emerging formats for next-generation antibody drug conjugates

Expert Opinion on Drug Discovery
Mahendra P DeonarainJared Marklew

Abstract

Antibody drug conjugates now make up a significant fraction of biopharma's oncology pipeline due to great advances in the understanding of the three key components and how they should be optimised together. With this clinical success comes innovation to produce new enabling technologies that can deliver more effective antibody-drug conjugates (ADCs) with a larger therapeutic index. There are many reviews that discuss the various strategies for ADCs design but the last 5 years or so have witnessed the emergence of a number of different antibody formats compete with the standard whole immunoglobulin. Using published research, patent applications and conference disclosures, the authors review the many antibody and antibody-like formats, discussing innovations in protein engineering and how these new formats impact on the conjugation strategy and ultimately the performance. The alternative chemistries that are now available offer new linkages, stability profiles, drug:antibody ratio, pharmacokinetics and efficacy. The different sizes being considered promise to address issues, such as tumour penetration, circulatory half-life and side-effects. ADCs are at the beginning of the next stage in their evolution and as these newer formats...Continue Reading

References

Jun 5, 2003·Nature Biotechnology·Svetlana O DoroninaPeter D Senter
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kevin J HamblettJoseph A Francisco
Aug 6, 2005·Protein Science : a Publication of the Protein Society·Lintao WangWei Zhang
Sep 10, 2005·Nature Biotechnology·Philipp Holliger, Peter J Hudson
Feb 21, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kam Fai TseWilliam J LaRochelle
Apr 28, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dangshe MaWilliam C Olson
Jan 11, 2007·Cancer Research·Mark S DennisRalph Schwall
Jan 18, 2007·Bioconjugate Chemistry·Sibu BalanSteve Brocchini
Nov 2, 2007·International Journal of Cancer. Journal International Du Cancer·Manpreet BhattiMahendra P Deonarain
Jul 22, 2008·Nature Biotechnology·Jagath R JunutulaWilliam Mallet
Aug 30, 2008·Molecular Cancer Therapeutics·Kristine M KimPaul J Carter
Sep 16, 2008·Molecular Cancer Therapeutics·Charlotte F McDonaghPaul J Carter
May 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Silke MetzUlrich Brinkmann
Sep 22, 2011·Journal of Pharmaceutical Sciences·Timothy M LauerBernhardt L Trout
Dec 17, 2011·Angewandte Chemie·Gonçalo J L BernardesDario Neri
Mar 8, 2012·Journal of the American Chemical Society·Giulio CasiDario Neri
Mar 23, 2012·Nature Reviews. Cancer·Andrew M ScottLloyd J Old
Mar 30, 2012·Journal of the National Cancer Institute·Gerhard MoldenhauerHeinz Faulstich
Jun 5, 2012·Advanced Drug Delivery Reviews·Dana Litvak-Greenfeld, Itai Benhar
Jul 24, 2012·Cancer Chemotherapy and Pharmacology·Diego A GianolioBeverly A Teicher
Mar 1, 2011·Therapeutic Delivery·Victor S Goldmacher, Yelena V Kovtun
Sep 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jun Y AxupPeter G Schultz
Dec 12, 2012·Cancer Immunology, Immunotherapy : CII·Boris Gorovits, Corinna Krinos-Fiorotti
Dec 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Paresh AgarwalCarolyn R Bertozzi
Dec 21, 2012·Chemical Biology & Drug Design·John A FlygarePaul Aristoff
Jan 22, 2013·Bioanalysis·Surinder KaurMontserrat Carrasco-Triguero
Mar 26, 2013·Natural Product Reports·Hans-Peter GerberRobert T Abraham
Mar 29, 2013·Nature Reviews. Drug Discovery·Rachel S ZolotRyan P Million
Jun 13, 2013·Methods : a Companion to Methods in Enzymology·Xiuling LiChristoph Rader
Jun 26, 2013·Evidence-based Dentistry·Ronald I Maitland

❮ Previous
Next ❯

Citations

Mar 10, 2016·Nature Communications·Taek-Chin CheongRoberto Chiarle
Aug 1, 2015·Bioanalysis·Montserrat Carrasco-Triguero
May 12, 2016·Advanced Materials·Małgorzata A WronskaJ Gerard Wall
Apr 28, 2016·Expert Opinion on Drug Delivery·Sam MassaNick Devoogdt
Jun 24, 2016·Biotechnology Letters·Ray Bakhtiar
Aug 10, 2016·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·H PyeL B Lovat
Jul 13, 2017·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Laia Montoliu-GayaSandra Villegas
Jan 7, 2020·Médecine sciences : M/S·Alain BeckNicolas Joubert
Mar 4, 2020·Biomolecules·Kelvin K TsaoJeffrey W Keillor
Aug 29, 2019·Organic & Biomolecular Chemistry·Kanwen YangPradeep K Dhal
Mar 31, 2018·Antibodies·Mahendra P DeonarainAshleigh C Stewart
Jul 10, 2020·Chemical Society Reviews·Maryam RahmatiHåvard J Haugen
Mar 18, 2017·Nature Reviews. Drug Discovery·Alain BeckNathalie Corvaïa
Sep 18, 2020·Pharmaceuticals·Nicolas JoubertCaroline Denevault-Sabourin
Feb 10, 2021·Nature Reviews. Clinical Oncology·Joshua Z DragoSarat Chandarlapaty
May 18, 2021·Frontiers in Immunology·Cecilie KnudsenAndreas H Laustsen
Apr 4, 2018·ACS Synthetic Biology·Christine E KaiserJohn Karanicolas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.